FDA Clears Roche’s PCR-Based MRSA Nasal Test

Jul 15, 2010

Premium

The US Food and Drug Administration has cleared Roche Molecular System's LightCycler MRSA Advanced Test for detecting methicillin-resistant Staphylococcus aureus for clinical use in the US, Roche said this week.

Roche's test becomes the third PCR-based MRSA test approved for clinical use in the US, joining Cepheid's Xpert MRSA/SA nasal assay for its GeneXpert PCR platform; and Becton Dickinson's GeneOhm MRSA assay, which runs on Cepheid's SmartCycler platform.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

Featured White Papers

Discovering Neuronal Cell Types

xMAP Cookbook: A collection of methods and protocols for developing multiplex assays with xMAP Technology

Jan

30

Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan

30

Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Main menu